Editorial: Dysregulation of immunity predisposing to severe COVID-19 infection
Front Immunol
.
2022 Dec 2:13:1099089.
doi: 10.3389/fimmu.2022.1099089.
eCollection 2022.
Authors
Rabih Halwani
1
2
3
,
Federica Pulvirenti
4
,
Saleh Al-Muhsen
5
Affiliations
1
Research Institute of Medical & Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.
2
Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
3
Prince Abdullah Ben Khaled Celiac Disease Research Chair, Department of Pediatrics, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia.
4
Reference Centre for Primary Immune Deficiencies, Azienda Ospedaliera Universitaria Policlinico Umberto I, Rome, Italy.
5
Immunology Research Laboratory, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
PMID:
36532010
PMCID:
PMC9755841
DOI:
10.3389/fimmu.2022.1099089
No abstract available
Keywords:
COVID-19; SARS-CoV-2; biomarker; inborn errors of immunity; primary immunodeficiency.
Publication types
Editorial
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19*
Disease Susceptibility
Humans